Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

Alexion Pharmaceutiacal names interim CEO and CFO

Alexion Pharmaceutiacal names interim CEO and CFO They succeed David Hallal and Vikas Sinha, who both stepped down from their roles amid an investigation into the company's sales practices for rare blood disease therapy Soliris (eculizumab).

Bio investors react as Clinton tweet pledges pricing crackdown

Bio investors react as Clinton tweet pledges pricing crackdown Alexion's 3.6% fall stems from the fact that it sells the world's most expensive drug - Soliris (eculizumab) for two ultra-rare diseases - which costs more than 500, 000

Humira remains top pharma product, but Sovaldi closes in

Humira remains top pharma product, but Sovaldi closes in The rare disease drug Soliris (eculizumab) has also made an appearance in the top 50 list - but only just - taking forty-eight place with sales of $2.2bn in 2014, registering ... But with rarity comes a high cost, with Soliris' price tag around $500, 000

Alexion expands in Ireland with new biofacility

Alexion expands in Ireland with new biofacility At the moment Alexion's only marketed drug is $2bn-seller Soliris (eculizumab) for two rare blood conditions. ... The new facility in Blanchardstown will "support the production and distribution of our medicine, Soliris, and our strong pipeline of

Alexion boosts rare disease portfolio with $8.4bn Synageva buy

Alexion boosts rare disease portfolio with $8.4bn Synageva buy Deal will help bolster firm's offering which is currently headed by aHUS drug Soliris.  . ... Kanuma adds to Alexion's own rare disease franchise, currently headed by Soliris (eculizumab) for rare blood clot conditions paroxysmal nocturnal

[ Previous 5 results ] 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...

Infographics